16 Lymphoma Clinical Trials in Commack, NY (2026)

Q: How do I join a clinical trial in Commack?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Commack research site will contact you.

Recruiting Lymphoma Studies in Commack

NCT00582621Recruiting

Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders

The purpose of this study is to better understand the genetic causes of Hodgkin's disease (a kind of lymphoma) and non-Hodgkin's lymphoma, as well as multiple myeloma, leukemia, and related diseases. ...

Commack, NY500 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07029217Recruiting

A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas

The researchers are doing this study to find out whether a very low dose of radiation therapy (VLDRT) is an effective treatment for people with follicular lymphoma (FL) or marginal zone lymphoma (MZL)...

Commack, NYPHASE3375 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT03618550Recruiting

Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

The purpose of this study is to test any good and bad effects of the study drug, pembrolizumab, in combination with GVD in the treatment of Hodgkin lymphoma....

Commack, NYPHASE2257 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05389293Recruiting

A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma

The purpose of this study is to find out if mosunetuzumab is an effective treatment in people with follicular lymphoma that was recently diagnosed and have not yet received any treatments for their di...

Commack, NYPHASE2152 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT02974647Recruiting

Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma

The purpose of this study is to test any good and bad effects of the study drug called ruxolitinib. Ruxolitinib works by blocking a protein called JAK. JAK works along with another protein called STAT...

Commack, NYPHASE283 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06377566Recruiting

A Study of BV-AVD in People With Bulky Hodgkin Lymphoma

The purpose of this study is to test whether BV-AVD is an effective treatment in people with early stage, bulky Hodgkin lymphoma that was recently diagnosed and who have not yet received any treatment...

Commack, NYPHASE271 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05010005Recruiting

A Study of Ruxolitinib and Duvelisib in People With Lymphoma

This study will test the safety of ruxolitinib, given at one dose that does not change, and duvelisib, given at different doses, to find out what effects, if any, the study treatment has on people wit...

Commack, NYPHASE170 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06736613Recruiting

A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma

The purpose of this study is to find out how many people with B-cell lymphoma who are at high risk for central nervous system/CNS relapse test positive for cerebral spinal fluid/CSF ctDNA but test neg...

Commack, NYPHASE250 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06765317Recruiting

A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma

The researchers are doing this study to find out if the study treatment is an effective treatment that causes few or mild side effects in people with diffuse large B-cell lymphoma (DLBCL), high-grade ...

Commack, NYPHASE242 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07001384Recruiting

A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL)

The researchers are doing this study to see if alectinib in combination with duvelisib is a safe and effective time-limited treatment for people with relapsed or refractory ALK+ anaplastic large cell ...

Commack, NYPHASE130 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT04301076Recruiting

Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

This phase I trial studies the side effects and best dose of lenalidomide when given together with usual combination chemotherapy (etoposide, prednisone, vincristine sulfate \[Oncovin\], cyclophospham...

Commack, NYPHASE130 participantsNational Cancer Institute (NCI)

View Study Details

NCT07082868Recruiting

A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL)

The purpose of this study is to find out whether the combination of epcoritamab and ibrutinib is a safe treatment approach that causes few or mild side effects in people with relapsed/refractory prima...

Commack, NYPHASE126 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06756308Recruiting

A Study of Enasidenib in People With T-Cell Lymphoma

The researchers are doing this study to find out whether enasidenib is a safe treatment for people with angioimmunoblastic T-cell lymphoma (AITL) that has an IDH2 mutation. The researchers will look a...

Commack, NYPHASE225 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07249528Recruiting

A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy

The purpose of this study is to collect voice recordings and nervous system (neurologic) assessments from people with non-Hodgkin lymphoma (NHL) or multiple myeloma (MM) who are receiving standard tre...

Commack, NY20 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05296304Recruiting

A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides

The researchers are doing this study to test the safety of combining bexarotene with TSEB radiotherapy in people who have a common form of CTCL called mycosis fungoides (MF). Bexarotene is a form of ...

Commack, NYPHASE120 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07137494Recruiting

A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL)

This study will test whether MB-CART19.1 is a safe and effective treatment for central nervous system lymphoma (CNSL). This study will test different doses of MB-CART19.1 to find the highest dose that...

Commack, NYPHASE112 participantsMemorial Sloan Kettering Cancer Center

View Study Details

About Lymphoma Clinical Trials in Commack

Lymphoma is a cancer of the lymphatic system that affects infection-fighting cells called lymphocytes. The two main types are Hodgkin lymphoma and non-Hodgkin lymphoma. Treatment often includes chemotherapy, radiation, immunotherapy, and in some cases stem cell transplant.

There are currently 16 lymphoma clinical trials recruiting participants in Commack, NY. These studies are seeking a combined 1,763 participants. Research is being sponsored by Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI). Clinical trial participation is free and participants receive study-related medical care at no cost.

Lymphoma Clinical Trials in Commack — FAQ

Are there lymphoma clinical trials in Commack?

Yes, there are 16 lymphoma clinical trials currently recruiting in Commack, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Commack?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Commack research site will contact you about next steps.

Are clinical trials in Commack free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Commack studies also compensate for your time and travel.

What lymphoma treatments are being tested?

The 16 active trials in Commack are testing new therapies including novel drugs, biologics, and treatment approaches for lymphoma.

Data updated July 20, 2026 from ClinicalTrials.gov